[An evaluation of the epidemiological and economic efficacy of immunizing adults with the Vaxigrippe vaccine].
The results of the evaluation of the epidemiological and economic efficiency of the immunization of the adult population with the vaccine Vaxigrip (Pasteur Mérieux Connaught, France) are presented. In accordance with the results obtained in this investigation, this vaccine was found to have pronounced epidemiological (prophylactic) efficiency and to be well tolerated. To achieve a perceptible epidemiological effect, it was sufficient to cover 43% of the group with vaccination. The economic effect of the use of Vaxigrip exceeded the costs connected with carrying out vaccination sixfold.
Sharipova
I S
IS
City Centre of the State Sanitary and Epidemiological Surveillance, State Medical Academy, Perm, Russia.
Kuz'minykh
S I
SI
Fel'dblium
I V
IV
D000328:Adult; D004341:Drug Evaluation; D006801:Humans; D015994:Incidence; D007252:Influenza Vaccines / Q000009:adverse effects / Q000191:economics / Q000276:immunology*; D007251:Influenza, Human / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D012426:Russia / Q000453:epidemiology; D011795:Surveys and Questionnaires
D007252:Influenza Vaccines
Otsenka épidemiologicheskoĭ i ékonomicheskoĭ éffektivnosti immunizatsii vzroslykh vaktsinoĭ Vaksigrip.